UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 169

Sortiert nach

User-friendly search interface for older adults: supporting search goal refreshing in working memory to improve information search strategies

Behaviour & information technology, 2020-10, Vol.39 (10), p.1094-1109

2020

Volltextzugriff (PDF)

Management of perioperative iron deficiency anemia as part of patient blood management in France: A budget impact model‐based analysis based on real world data

Transfusion (Philadelphia, Pa.), 2023-09, Vol.63 (9), p.1692-1700

2023

Volltextzugriff (PDF)

Hybrid medicines in France. Hybrid medicines: Overviews in France and in Paris Public Hospitals

Annales pharmaceutiques françaises, 2021-11, Vol.79 (6), p.664-689

2021

Volltextzugriff (PDF)

Investigating multimedia effects on concept map building: Impact on map quality, information processing and learning outcome

Education and information technologies, 2019-11, Vol.24 (6), p.3645-3667

2019

Volltextzugriff (PDF)

Assessment of the budgetary impact of an emicizumab therapy introduction for patients with severe haemophilia A without inhibitor

Annales pharmaceutiques françaises, 2023-05, Vol.81 (3), p.529-537

2023

Volltextzugriff (PDF)

Comparative analysis of the financing of follow-up and rehabilitation care institutions and public mental health institutions: Application for innovative and expensive drugs

Annales pharmaceutiques françaises, 2021-11, Vol.79 (6), p.690-699

2021

Volltextzugriff (PDF)

Prices of Orphan Drugs in Four Western European Countries Before and After Market Exclusivity Expiry: A Cross-Country Comparison of List Prices and Purchase Prices

Applied health economics and health policy, 2023-11, Vol.21 (6), p.905-914

2023

Volltextzugriff (PDF)

Security of supply: Getting to know more about the organization of suppliers

Annales pharmaceutiques françaises, 2022-01, Vol.80 (1), p.89-100

2022

Volltextzugriff (PDF)

Assessment of the use by hospital pharmacists of the opinions issued by the Haute Autorité de santé and the economic analysis tools proposed to them

Annales pharmaceutiques françaises, 2019-03, Vol.77 (2), p.159-167

2019

Volltextzugriff (PDF)

Health technology assessment of innovative medical devices: Timing and decision at national and local level

Annales pharmaceutiques françaises, 2020-03, Vol.78 (2), p.189-197

2020

Volltextzugriff (PDF)

Economic impact of etanercept and adalimumab biosimilars on hospitals scale covered by PharmAlp'Ain, a hospitals grouping of orders for health products

Annales pharmaceutiques françaises, 2018-01, Vol.76 (1), p.57-63

2018

Volltextzugriff (PDF)

Impact of the expiry of the patent on quality and price of medicines at hospital: Study of five anticancer drugs from 2008 to 2015 at the Assistance publique-Hôpitaux de Paris

Annales pharmaceutiques françaises, 2017-01, Vol.75 (1), p.59-66

2017

Volltextzugriff (PDF)

Melatonin in children with autistic spectrum disorders: recent and practical data

European child & adolescent psychiatry, 2011-05, Vol.20 (5), p.231-239

2011

Volltextzugriff (PDF)

The French Public Health Care System: An Original Way for Cost Saving

Value in health, 2013-11, Vol.16 (7), p.A400-A400

2013

Volltextzugriff (PDF)

Evaluation of dental medical devices: Focus on the definition of needs

Annales pharmaceutiques françaises, 2019-05, Vol.77 (3), p.232-240

2019

Volltextzugriff (PDF)

Market access agreements: Definition and features. Could MAA be defined as a solution for immunotherapy funding by French health system?

Annales pharmaceutiques françaises, 2018-07, Vol.76 (4), p.265-272

2018

Volltextzugriff (PDF)

Determinants of Hospitals' Attractiveness For Patients: Application to Expensive Drugs

Value in health, 2014-11, Vol.17 (7), p.A421-A421

2014

Volltextzugriff (PDF)

Review of patient-specific instrumentation for total knee prosthesis

Annales pharmaceutiques françaises, 2018-05, Vol.76 (3), p.228-234

2018

Volltextzugriff (PDF)

HPR194 New Framework for Early Access to Drugs in France: Feedback After a One-Year Use in University Public Hospitals of Paris

Value in health, 2023-12, Vol.26 (12), p.S287

2023

Volltextzugriff (PDF)

OP8 A New Complement Inhibitor: Impact of Ravulizumab on Eculizumab and Future Biosimilars Use, and Role of Paris Public Hospitals (AP-HP)

Value in health, 2023-12, Vol.26 (12), p.S443

2023

Volltextzugriff (PDF)

HPR153 Market Access Strategies for Advanced Therapy Drugs: A Comparative Analysis of the European and American Markets, Authorizations and Withdrawals

Value in health, 2023-12, Vol.26 (12), p.S280

2023

Volltextzugriff (PDF)

EE124 Analysis of the Use of the Haute Autorité De Santé (HAS) Opinions by Hospital Pharmacists in France

Value in health, 2023-12, Vol.26 (12), p.S74

2023

Volltextzugriff (PDF)

EE616 Management of Chronic Lymphocytic Leukemia: What Impact on Consumption and Expenditure?

Value in health, 2022-12, Vol.25 (12), p.S177-S177

2022

Volltextzugriff (PDF)

HPR154 Appropriate Use of Anti-PD(L)1 in Paris Public Hospitals (AP-HP): Are the Prescriptions in Compliance with Reimbursed Indications?

Value in health, 2022-12, Vol.25 (12), p.S260-S260

2022

Volltextzugriff (PDF)

HPR26 Anti-PD(L)1: Does the Cost of Treatment Have an Impact on the Therapeutic Decision-Making?

Value in health, 2022-12, Vol.25 (12), p.S237-S237

2022

Volltextzugriff (PDF)

1 – 25 von 169

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(140)
Mit Volltextzugriff
(134)

Publikationsform

Artikel
(168)
Tagungsberichte
(1)

Sprache

Englisch
(118)
Französisch
(65)

Erscheinungsjahr

n.n

Thema

Internal Medicine
(26)
Science & Technology
(13)
Humans
(12)
Life Sciences & Biomedicine
(12)
France
(8)
Pharmacology & Pharmacy
(8)
Hospitals
(7)
Sciences Biologiques Et Medicales
(7)
Sciences Medicales
(7)
Hospital
(6)
Pharmacologie. Traitements Medicamenteux
(5)
Prices
(5)
Anticancéreux
(4)
Drugs
(4)
Hybrid Medicines
(4)
Pharmacy
(4)
Social Sciences
(4)
Anticancer Drugs
(3)
Antineoplastic Agents
(3)
Antineoplastic Agents - Economics
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

User-friendly search interface for older adults: supporting search goal refreshing in working memory to improve information search strategies

Management of perioperative iron deficiency anemia as part of patient blood management in France: A budget impact model‐based analysis based on real world data

Hybrid medicines in France. Hybrid medicines: Overviews in France and in Paris Public Hospitals

Investigating multimedia effects on concept map building: Impact on map quality, information processing and learning outcome

Assessment of the budgetary impact of an emicizumab therapy introduction for patients with severe haemophilia A without inhibitor

Comparative analysis of the financing of follow-up and rehabilitation care institutions and public mental health institutions: Application for innovative and expensive drugs

Prices of Orphan Drugs in Four Western European Countries Before and After Market Exclusivity Expiry: A Cross-Country Comparison of List Prices and Purchase Prices

Security of supply: Getting to know more about the organization of suppliers

Assessment of the use by hospital pharmacists of the opinions issued by the Haute Autorité de santé and the economic analysis tools proposed to them

Health technology assessment of innovative medical devices: Timing and decision at national and local level

Economic impact of etanercept and adalimumab biosimilars on hospitals scale covered by PharmAlp'Ain, a hospitals grouping of orders for health products

Impact of the expiry of the patent on quality and price of medicines at hospital: Study of five anticancer drugs from 2008 to 2015 at the Assistance publique-Hôpitaux de Paris

Melatonin in children with autistic spectrum disorders: recent and practical data

The French Public Health Care System: An Original Way for Cost Saving

Evaluation of dental medical devices: Focus on the definition of needs

Market access agreements: Definition and features. Could MAA be defined as a solution for immunotherapy funding by French health system?

Determinants of Hospitals' Attractiveness For Patients: Application to Expensive Drugs

Review of patient-specific instrumentation for total knee prosthesis

HPR194 New Framework for Early Access to Drugs in France: Feedback After a One-Year Use in University Public Hospitals of Paris

OP8 A New Complement Inhibitor: Impact of Ravulizumab on Eculizumab and Future Biosimilars Use, and Role of Paris Public Hospitals (AP-HP)

HPR153 Market Access Strategies for Advanced Therapy Drugs: A Comparative Analysis of the European and American Markets, Authorizations and Withdrawals

EE124 Analysis of the Use of the Haute Autorité De Santé (HAS) Opinions by Hospital Pharmacists in France

EE616 Management of Chronic Lymphocytic Leukemia: What Impact on Consumption and Expenditure?

HPR154 Appropriate Use of Anti-PD(L)1 in Paris Public Hospitals (AP-HP): Are the Prescriptions in Compliance with Reimbursed Indications?

HPR26 Anti-PD(L)1: Does the Cost of Treatment Have an Impact on the Therapeutic Decision-Making?

Aktive Filter

Suchergebnisse filtern